ENTITY

Dogwood Therapeutics (DWTX US)

11
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Exchange Announcement • 29 Nov 2025 03:15
Exchange Announcement • 29 Nov 2025 03:00
Exchange Announcement • 22 Nov 2025 02:01
Exchange Announcement • 07 Nov 2025 21:45
Exchange Announcement • 06 Nov 2025 22:15
x